What happens after diagnosis
Published
Just been told you have prostate cancer? Read what happens next – the investigation, the assessment of aggressiveness and the decisions you need to make.
Blog about prostate cancer, AI diagnostics and second opinions
Read articles on prostate cancer, the limits of the Gleason method, AI in healthcare and when a second opinion can be decisive for your treatment decision.
Article overview
After the diagnosis
- What happens after a prostate cancer diagnosis? 5 steps you should know about Article 1 – What happens after diagnosis
- How certain is your prostate cancer diagnosis, really? Article 2 – How certain is the diagnosis
Treatment choices
- Should you have prostate surgery? 3 things you should know first
- Active surveillance or surgery – how is it decided? Surveillance vs. surgery
Method and analysis
- What is the Gleason score and why can it be misleading? Article 5 – Gleason score explained
- Can AI analyse prostate cancer better than a specialist?
- PCAI vs. Gleason score – a direct comparison of the methods Article 7 – PCAI vs Gleason
Practical
Related: Article 1 – What happens after diagnosis | Article 2 – How certain is the diagnosis | Article 6 – Can AI analyse cancer better | Article 7 – PCAI vs Gleason | Article 8 – Where can I get a second opinion?
Do you have questions about your own diagnosis?
We go through your situation and what a second opinion can add – free of charge, and you only order a second opinion if you feel afterwards that it is right for you.
All articles
How certain is the diagnosis
Published
Up to 20% of prostate cancer assessments may be incorrect. Read what the research shows and why a second opinion can be decisive before a treatment decision.
Should you have prostate surgery?
Published
Should you have prostate surgery? Read about the risks of the operation, when active surveillance is an option and why diagnostic precision is decisive.
Gleason score explained
Published
What is the Gleason score and why can it be misleading? Read about the method, inter-observer variability and the 20% figure – explained for patients.
Can AI analyse cancer better
Published
Can AI beat a specialist? In clinical studies PCAI outperformed all three experienced pathologists on the test dataset from Malmö. Read what the research shows.
PCAI vs Gleason
Published
PCAI gives an index of 1–100 with 7 risk levels. Gleason gives 1–5 with high subjectivity. Read the full comparison of the two methods and what the data show.